TY - JOUR
T1 - t(10; 12) (q24; p13) as the sole abnormality in a case with refractory acute myeloid leukemia
T2 - The first case report and literature review.
AU - Lu, Gary
AU - Gurevich, Inga
AU - Vo, Binh T.
AU - Chen, S. S.
N1 - Copyright:
This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
PY - 2009/8/18
Y1 - 2009/8/18
N2 - Rearrangements involving chromosome region at 12p13 are common abnormalities in hematological malignancies, including myeloid and lymphoid types. ETV6 gene is usually involved in the 12p13 region. ETV6 rearrangements are more often observed in acute lymphoblastic leukemia than in acute myeloid leukemia (AML), where ETV6 gene deletions are more common than rearrangements. Here, we report an AML case with the recurrent t(10; 12) (q24; p13) as the sole abnormality. Fluorescence in situ hybridization with mapping back to metaphases confirmed that the ETV6 gene splits, and rearranges with a locus at 10q24. In review of the literature, this is the first report of AML case with the novel abnormality as the sole change. Complete laboratory findings from bone marrow examination, flow cytometry analysis, cytogenetic studies, molecular analysis, and clinical features are also described in the report.
AB - Rearrangements involving chromosome region at 12p13 are common abnormalities in hematological malignancies, including myeloid and lymphoid types. ETV6 gene is usually involved in the 12p13 region. ETV6 rearrangements are more often observed in acute lymphoblastic leukemia than in acute myeloid leukemia (AML), where ETV6 gene deletions are more common than rearrangements. Here, we report an AML case with the recurrent t(10; 12) (q24; p13) as the sole abnormality. Fluorescence in situ hybridization with mapping back to metaphases confirmed that the ETV6 gene splits, and rearranges with a locus at 10q24. In review of the literature, this is the first report of AML case with the novel abnormality as the sole change. Complete laboratory findings from bone marrow examination, flow cytometry analysis, cytogenetic studies, molecular analysis, and clinical features are also described in the report.
UR - http://www.scopus.com/inward/record.url?scp=79952117258&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79952117258&partnerID=8YFLogxK
M3 - Review article
C2 - 19727243
AN - SCOPUS:79952117258
SN - 1671-167X
VL - 41
SP - 480
EP - 483
JO - Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
JF - Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
IS - 4
ER -